American Gene Technologies
Phase 1American Gene Technologies™ (AGT) is a gene and cell therapeutics company with a proprietary lentiviral platform capable of broad applications. AGT expects its lead candidate for an HIV cure to enter the clinic in 2018, and it has developed a patented immuno-oncology approach to attack a variety of epithelial cancers.
Founded
2008
Focus
RNA & Gene TherapyCell & Gene Therapy
About
American Gene Technologies™ (AGT) is a gene and cell therapeutics company with a proprietary lentiviral platform capable of broad applications. AGT expects its lead candidate for an HIV cure to enter the clinic in 2018, and it has developed a patented immuno-oncology approach to attack a variety of epithelial cancers.
Funding History
2Total raised: $60.5M
Grant$500KMaryland Stem Cell Research FundMar 15, 2021
Series A$60MUndisclosedDec 15, 2020
Company Info
TypePrivate
Founded2008
LocationRockville, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile